Proteomic and lipidomic profiling of tumor-derived exosomes for cancer prevention

用于癌症预防的肿瘤源性外泌体的蛋白质组学和脂质组学分析

基本信息

  • 批准号:
    8230499
  • 负责人:
  • 金额:
    $ 8.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Early and frequent screening for colorectal cancer will enable detection of localized early-stage tumors while they are still treatable, thus significantly reducing the drastic mortality rate associated with this disease. To achieve this, we propose to take the novel approach of combining lipidomic and proteomic analysis of colorectal cancer-derived exosomes in an effort to prevent colon cancer by improving our understanding of colorectal cancer biology and cell-cell communication and by defining a catalogue of tissue-specific markers that can be used as tools to screen, stage, and follow the treatment of patients. Exosomes are unique encapsulated vesicles that are secreted from cells and transported away from the originating site to interact with their localized environment or transported around the body through blood. Their unique proteomic profiles are specific to the tumor cell and thus provide an opportunity to define tissue origin and status. This information can be used to improve diagnostic strategies for the prevention of late stage colorectal cancer and to gain further insight into colorectal cancer biology. First, we will define a purification protocol for normal colon epithelial and colorectal cancer-derived exosomes. We will use newly developed lipidomic approaches to quantitatively determine the lipid profile that defines tumor-specific exosomes. The combination of lipidomic analysis and proteomic analysis, with an overlay of tissue-specific proteins will provide a set of markers that will uniquely identify tissue-specific tumor-derived exosomes that are present in many body fluids. This unique approach of integrating quantitative exosomal lipid profiles with protein profiles will ultimately advance our understanding of exosome function in colorectal cancer biology and enable the identification of highly informative and clinically useful biomarkers.
描述(由申请人提供): 结肠直肠癌的早期和频繁筛查将使局部早期肿瘤的检测,而他们仍然是可治疗的,从而显着降低与这种疾病相关的急剧死亡率。为了实现这一目标,我们建议采取一种新的方法,将结直肠癌来源的外泌体的脂质组学和蛋白质组学分析相结合,通过提高我们对结直肠癌生物学和细胞间通讯的理解,并通过定义一系列组织特异性标志物来预防结肠癌,这些标志物可用作筛选,分期和随访患者治疗的工具。外泌体是独特的囊泡,其从细胞分泌并从起始位点转运离开以与其局部环境相互作用或通过血液在体内转运。它们独特的蛋白质组谱对肿瘤细胞具有特异性,因此提供了确定组织起源和状态的机会。这些信息可用于改善预防晚期结直肠癌的诊断策略,并进一步了解结直肠癌生物学。首先,我们将定义正常结肠上皮和结直肠癌来源的外泌体的纯化方案。我们将使用新开发的脂质组学方法来定量确定定义肿瘤特异性外泌体的脂质谱。脂质组学分析和蛋白质组学分析与组织特异性蛋白质的叠加的组合将提供一组标志物,其将唯一地鉴定存在于许多体液中的组织特异性肿瘤来源的外泌体。这种将定量外泌体脂质谱与蛋白质谱相结合的独特方法将最终促进我们对结直肠癌生物学中外泌体功能的理解,并能够识别高度信息化和临床有用的生物标志物。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of peptide features in precursor spectra using Hardklör and Krönik.
使用 Hardklör 和 Krönik 鉴定前体光谱中的肽特征。
  • DOI:
    10.1002/0471250953.bi1318s37
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hoopmann,MichaelR;MacCoss,MichaelJ;Moritz,RobertL
  • 通讯作者:
    Moritz,RobertL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert L Moritz其他文献

Robert L Moritz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert L Moritz', 18)}}的其他基金

COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics
COPD 易感性、异质性和进展:蛋白质组学和遗传学
  • 批准号:
    10535208
  • 财政年份:
    2017
  • 资助金额:
    $ 8.59万
  • 项目类别:
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics
COPD 易感性、异质性和进展:蛋白质组学和遗传学
  • 批准号:
    10678877
  • 财政年份:
    2017
  • 资助金额:
    $ 8.59万
  • 项目类别:
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics
COPD 易感性、异质性和进展:蛋白质组学和遗传学
  • 批准号:
    9912815
  • 财政年份:
    2017
  • 资助金额:
    $ 8.59万
  • 项目类别:
Proteomic and lipidomic profiling of tumor-derived exosomes for cancer prevention
用于癌症预防的肿瘤源性外泌体的蛋白质组学和脂质组学分析
  • 批准号:
    8116401
  • 财政年份:
    2011
  • 资助金额:
    $ 8.59万
  • 项目类别:
FAIMS-Selected Reaction Monitoring to Quantitative Protein Networks in Disease
FAIMS 对疾病定量蛋白质网络的选择反应监测
  • 批准号:
    8052984
  • 财政年份:
    2011
  • 资助金额:
    $ 8.59万
  • 项目类别:
Proteomic Core
蛋白质组核心
  • 批准号:
    9129676
  • 财政年份:
  • 资助金额:
    $ 8.59万
  • 项目类别:
Proteomic Core
蛋白质组核心
  • 批准号:
    8517255
  • 财政年份:
  • 资助金额:
    $ 8.59万
  • 项目类别:
Proteomic Core
蛋白质组核心
  • 批准号:
    8539500
  • 财政年份:
  • 资助金额:
    $ 8.59万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 8.59万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 8.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了